UPDATE 2-Japan's Eisai sets price tag of about $16,000 on liver cancer drug

UPDATE 2-Japan's Eisai sets price tag of about $16,000 on liver cancer drug


Japan's Eisai Co Ltd said on Thursday it would price its cancer drug Lenvima at about $16,000 for a month's supply before discounts, after the U.S. Food and Drug Administration approved its use in patients with a common form of liver cancer. The drug was approved as the first therapy in over a decade in the United States to treat previously untreated patients with an advanced or intermediate stage of unresectable hepatocellular carcinoma .



from Biotech News